Stifel Financial Corp United Therapeutics Corp Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Stifel Financial Corp holds 6,913 shares of UTHR stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,913
Previous 6,930 0.25%
Holding current value
$2.61 Million
Previous $2.21 Million 12.23%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $5,287 - $6,180
-17 Reduced 0.25%
6,913 $2.48 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $329,607 - $460,693
1,444 Added 26.32%
6,930 $2.21 Million
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $66,810 - $79,094
317 Added 6.13%
5,486 $1.26 Million
Q4 2023

Feb 12, 2024
SELL
$214.88 - $256.94 $22,992 - $27,492
-107 Reduced 2.03%
5,169 $1.14 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $2,330 - $2,730
-11 Reduced 0.21%
5,276 $1.19 Million
Q2 2023

Aug 14, 2023
SELL
$205.19 - $232.99 $96,849 - $109,971
-472 Reduced 8.2%
5,287 $1.17 Million
Q1 2023

May 12, 2023
SELL
$212.99 - $276.17 $250,902 - $325,328
-1,178 Reduced 16.98%
5,759 $1.29 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $138,192 - $188,168
-671 Reduced 8.82%
6,937 $1.93 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $14,434 - $17,336
-71 Reduced 0.92%
7,608 $1.59 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $326,719 - $450,690
1,869 Added 32.17%
7,679 $1.81 Million
Q1 2022

May 13, 2022
BUY
$166.16 - $213.96 $1,827 - $2,353
11 Added 0.19%
5,810 $1.04 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $107,089 - $125,542
-581 Reduced 9.11%
5,799 $1.25 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $539 - $644
3 Added 0.05%
6,380 $1.18 Million
Q2 2021

Aug 13, 2021
BUY
$170.47 - $211.93 $36,139 - $44,929
212 Added 3.44%
6,377 $1.14 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $8,774 - $9,966
-57 Reduced 0.92%
6,165 $1.03 Million
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $110,019 - $163,933
1,080 Added 21.0%
6,222 $945,000
Q3 2020

Nov 16, 2020
SELL
$99.9 - $121.13 $17,182 - $20,834
-172 Reduced 3.24%
5,142 $519,000
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $492,820 - $668,607
5,314 New
5,314 $643,000
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $148,393 - $235,700
-1,951 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$107.15 - $126.84 $209,049 - $247,464
1,951 New
1,951 $228,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email